Russell Investments Group’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-33,181
Closed -$167K 3271
2021
Q1
$167K Hold
33,181
﹤0.01% 2874
2020
Q4
$174K Hold
33,181
﹤0.01% 2787
2020
Q3
$173K Buy
+33,181
New +$191K ﹤0.01% 2821
2017
Q4
Sell
-16,565
Closed -$106K 2987
2017
Q3
$106K Hold
16,565
﹤0.01% 2767
2017
Q2
$87K Sell
16,565
-20,257
-55% -$114K ﹤0.01% 2824
2017
Q1
$220K Buy
36,822
+10,802
+42% +$65.1K ﹤0.01% 2679
2016
Q4
$159K Buy
+26,020
New +$183K ﹤0.01% 2763

Other funds holding MNOV

Russell Investments Group's MNOV Position: Q2 2021 in Review

Russell Investments Group sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 33,181 shares — an estimated $167K sold.

Russell Investments Group first reported a position in MNOV in Q4 2016 and held it in 7 quarters. The position peaked at $220K in Q1 2017. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

  • Russell Investments Group reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 33,181 MediciNova shares in Q2 2021, an estimated $167K.
  • Russell Investments Group first reported a position in MediciNova in Q4 2016 and held it in 7 quarters.
  • Russell Investments Group's MediciNova position peaked at $220K in Q1 2017.
  • 55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.